NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

10642	Companies
226308	Keywords
154798	Articles
119785	Press releases

Home
Companies
NanoViricides, Inc.

PRESS RELEASE

published on 06/04/2024 at 12:30, 2 years ago

The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
NanoViricides, Inc. reports positive pharmacokinetic profile of NV-387 in non-human primate model, showcasing sustained blood concentrations enabling less frequent dosing for its broad-spectrum antiviral agent. The unique polymeric design supports potential against RSV, COVID, and influenza

NV-387 NanoViricides Inc. Broad-spectrum Antiviral Agent Pharmacokinetic Profile RSV COVID Influenza
BRIEF

published on 05/29/2024 at 12:35, 2 years ago

NanoViricides Unveils Revolutionary Broad-Spectrum Antiviral Agent

NV-387 Clinical Trials Antiviral Nanomedicine Broad-spectrum
BRIEF

published on 05/29/2024 at 12:35, 2 years ago

NanoViricides dévoile un agent antiviral révolutionnaire à large spectre

NV-387 Essais Cliniques Antiviral Nanomédecine À Large Spectre
PRESS RELEASE

published on 05/29/2024 at 12:30, 2 years ago

A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
NanoViricides, Inc. elaborates on its groundbreaking host-mimetic, broad-spectrum antiviral technology platform, NV-387, designed to revolutionize viral infection treatment with advanced decoy mechanisms

NV-387 NanoViricides Inc. Broad-spectrum Host-mimetic Technology Antiviral Agent
BRIEF

published on 05/23/2024 at 12:35, 2 years 1 month ago

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.

NanoViricides NV-387 Partnership Antiviral Aagami
BRIEF

published on 05/23/2024 at 12:35, 2 years 1 month ago

NanoViricides renforce les efforts de partenariat - engage Aagami Inc.

NanoViricides NV-387 Partenariat Antiviral Aagami
PRESS RELEASE

published on 05/23/2024 at 12:30, 2 years 1 month ago

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
NanoViricides, Inc. engages Aagami, Inc. to seek licensing and partnering opportunities for its antiviral nanomedicines including key asset NV-387. Aagami to focus on India and Japan

NV-387 NanoViricides Inc. Antiviral Nanomedicines Aagami Inc. Licensing And Partnering Opportunities
BRIEF

published on 05/20/2024 at 12:35, 2 years 1 month ago

NV-387 Shows Promising Results in Treating Lethal RSV Infection in Animal Study

NanoViricides NV-387 Clinical Trials Antiviral RSV
BRIEF

published on 05/20/2024 at 12:35, 2 years 1 month ago

Le NV-387 montre des résultats prometteurs dans le traitement de l'infection mortelle par le VRS dans une étude animale

NanoViricides NV-387 Essais Cliniques Antiviral VRS
PRESS RELEASE

published on 05/20/2024 at 12:30, 2 years 1 month ago

Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NanoViricides, Inc. announces strong antiviral activity of NV-387 against RSV, Influenza A, and Coronaviruses in lethal lung infection models, potentially offering a cure for RSV infection

NV-387 Clinical Trials NanoViricides Inc. Antiviral RSV

Accesswire

Published on 06/26/2026 at 01:40, 5 hours 56 minutes ago

UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 8 hours 6 minutes ago

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 9 hours 6 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 10 hours 4 minutes ago

BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 16 hours 6 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation

View all ACCESSWIRE

EQS Group

Published on 06/26/2026 at 04:20, 3 hours 16 minutes ago

VARON Helps Travelers Breathe Easy This Summer With Portable Oxygen Concentrators Built for Mobility
Published on 06/26/2026 at 02:05, 5 hours 31 minutes ago

VARON Marks "Love Your Lungs Week" With a Call to Prioritize Summer Respiratory Health Across Europe
Published on 06/25/2026 at 22:40, 8 hours 56 minutes ago

DeFi Technologies Inc. Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Published on 06/25/2026 at 19:00, 12 hours 36 minutes ago

EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/25/2026 at 18:59, 12 hours 37 minutes ago

OHB Digital Connect completes upgrade of military ground stations

Les Echos

Published on 06/26/2026 at 07:00, 36 minutes ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 36 minutes ago

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 12 hours 51 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 13 hours 6 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 13 hours 46 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE